Guardant Health Inc (GH)
Who owns Guardant Health Inc (GH)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.4% of the shares are freely tradable; institutional investors hold 106.0%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.61 | 11,553,759 | +2.1 | 03/31/2026 |
| T. Rowe Price Associates, Inc. | 5.23 | 7,023,689 | +24.6 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.35 | 5,837,992 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.19 | 5,624,180 | +0.0 | 03/31/2026 |
| Amvescap Plc. | 3.69 | 4,946,469 | -7.0 | 03/31/2026 |
| The Goldman Sachs Group Inc | 3.31 | 4,435,839 | +68.8 | 03/31/2026 |
| Two Sigma Investments LLC | 3.15 | 4,229,531 | +94.7 | 03/31/2026 |
| FMR Inc | 3.07 | 4,116,081 | +71.8 | 03/31/2026 |
| Baillie Gifford & Co Limited. | 2.88 | 3,859,046 | -21.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Morn Total Stk Mkt Idx Investor | 2.98 | 4,000,355 | +0.8 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 21. Jul 2026 | Mignone Roberto | Director | Other | 264 | 0.00 | – |
| 17. Jul 2026 | Hidalgo Medina Manuel | Director | Other | 232 | 0.00 | – |
| 16. Jul 2026 | Tariq Musa | Director | Sell | 116 | 163.29 | 18,942 |
| 15. Jul 2026 | Tariq Musa | Director | Other | 250 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.